EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Orbimed Advisors LLC Acquires 150,000 Shares of Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Purchased by OMERS ADMINISTRATION Corp
Healthcare of Ontario Pension Plan Trust Fund Acquires 286,833 Shares of Bristol Myers Squibb Company $BMY
Renaissance Technologies LLC Lowers Stock Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Launches Revolutionary Onco-Derma Therapy Relopduo in India for Melanoma Treatment, ETPharma
Agilent Technologies (A) Is Up 5.4% After New OPDIVO-Linked PD-L1 Test Approval - Has The Bull Case Changed?
Hilltop Holdings Inc. Cuts Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Holdings Lowered by Dai ichi Life Insurance Company Ltd
Bristol Myers Squibb Company $BMY Shares Sold by Gabelli Funds LLC
Hilltop Holdings Inc. Lowers Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Best Pharmaceutical Stocks To Watch Now - July 25th
Why Agilent Technologies (A) Is Up 5.4% After New FDA Nod For OPDIVO Cancer Test
Bristol Myers Squibb Company $BMY Shares Purchased by GC Wealth Management RIA LLC
Entropy Technologies LP Sells 164,892 Shares of Bristol Myers Squibb Company $BMY
Cannell & Spears LLC Has $14.71 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer
Epoch Investment Partners Inc. Increases Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Johnson & Johnson (JNJ) Reports Early Phase 3 Win In Multiple Myeloma
3 Healthcare Stocks We Keep Off Our Radar
Knott David M Jr Sells 8,378 Shares of Bristol Myers Squibb Company $BMY - Markets Daily
Bristol Myers Squibb Company $BMY Shares Sold by Knott David M Jr
Oak Associates Ltd. OH Acquires New Position in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Stake Raised by Sei Investments Co.
Compound Planning Inc. Has $4.94 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily
Compound Planning Inc. Has $4.94 Million Holdings in Bristol Myers Squibb Company $BMY
Johnson And Johnson Stock And Other Defensive Dividend Picks For Uncertain Markets
Merck (MRK) Gets Fresh KEYTRUDA Momentum In EU Testing And Biliary Cancer Trials
KCM Capital Inc Invests $3.99 Million in Bristol Myers Squibb Company $BMY - Stock Observer
Measured Wealth Private Client Group LLC Purchases 18,842 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
Advancing antibody drug conjugates in gastrointestinal cancers
Povorcitinib for hidradenitis suppurativa: the randomized, double-blind, placebo-controlled STOP-HS1 and STOP-HS2 phase 3 trials
Bank of America Says the Fed Should Raise Rates Now: 4 Dividend Inflation-Resistant Stocks
Bristol Myers Squibb (BMY) Wins FDA Filing And Nvidia Tie Up, Is It Still Undervalued?
First Trust Advisors LP Raises Position in Bristol Myers Squibb Company $BMY
Bellwether Advisors LLC Purchases New Shares in Bristol Myers Squibb Company $BMY
Alexandria Real Estate Equities (ARE) Delivers 427,000 RSF Bristol Myers Squibb R And D Hub
Westpac Banking Corp Has $11.68 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer
Novartis (SWX:NOVN) Is Pushing AI Deeper Into Drug Discovery
Bellwether Advisors LLC Acquires New Holdings in Bristol Myers Squibb Company $BMY - Daily Political
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells
Independent Financial Group LLC Invests $976,000 in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Acquires Nvidia's Advanced AI System for Faster Drug Discovery, ETManufacturing
Bristol Myers Squibb Company $BMY Shares Bought by Meeder Asset Management Inc. - Stock Observer
HORAN Wealth LLC Grows Holdings in Bristol Myers Squibb Company $BMY - Daily Political
Erste Group Bank Has Positive Outlook of BMY FY2026 Earnings - Stock Observer
Epicardial adipose tissue thickness is associated with circulating biomarkers in individuals without known cardiac disease across a broad adiposity spectrum
Bristol Myers Expands NVIDIA Partnership to Build Top Life Sciences AI Supercomputer
Bristol Myers Squibb expands Nvidia partnership to supercharge its AI drug factory
Bristol Myers Squibb (BMY) Doubles Down on Nvidia (NVDA) AI Tech for Drug Development
Nvidia partners with Bristol-Myers Squibb to build AI supercomputer for drug discovery
Bristol Myers buys Nvidia's latest AI computing system for drug research
Pharmaceutical Stocks To Research - July 20th - Daily Political
Bristol Myers (BMY) Is Up 5.5% After FDA Accepts Mezigdomide NDA In Multiple Myeloma
Swiss National Bank Raises Stock Position in Bristol Myers Squibb Company $BMY - Markets Daily
SEB Asset Management AB Takes Position in Bristol Myers Squibb Company $BMY
Mediolanum International Funds Ltd Has $82.85 Million Holdings in Bristol Myers Squibb Company $BMY
Swiss National Bank Purchases 396,700 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
FDA-Approved PD-L1 Test for GI Cancers Could Be A Game Changer For Agilent Technologies (A)
Hillsdale Investment Management Inc. Has $101,000 Holdings in Bristol Myers Squibb Company $BMY
California Public Employees Retirement System Purchases 121,813 Shares of Bristol Myers Squibb Company $BMY
Allspring Global Investments Holdings LLC Boosts Stake in Bristol Myers Squibb Company $BMY
SteelPeak Wealth LLC Has $1.62 Million Stock Position in Bristol Myers Squibb Company $BMY - Daily Political
Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis
Bristol Myers Squibb Company $BMY Shares Purchased by Geneos Wealth Management Inc. - Markets Daily
Is Bristol-Myers Squibb (BMY) Reasonable After Its 32% Run?
Aware Super Pty Ltd as trustee of Aware Super Purchases New Shares in Bristol Myers Squibb Company $BMY - Daily Political
Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia
Investors Purchase High Volume of Call Options on Bristol Myers Squibb (NYSE:BMY) - Zolmax
Investors Buy Large Volume of Bristol Myers Squibb Call Options (NYSE:BMY)
Illinois Municipal Retirement Fund Sells 87,210 Shares of Bristol Myers Squibb Company $BMY
Bank of New York Mellon Corp Sells 1,194,538 Shares of Bristol Myers Squibb Company $BMY
Response kinetics and depth of response after idecabtagene vicleucel in relapsed/refractory multiple myeloma
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Morningstar
Diversify Wealth Management LLC Acquires 21,775 Shares of Bristol Myers Squibb Company $BMY
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada | Valuespectrum.com
Bristol-Myers Squibb on Pace for Largest Percent Decrease Since November 2025 - Data Talk | Morningstar
Bristol Myers Squibb (BMY) Following FDA Acceptance Has An Undervalued Case
Juvenile Idiopathic Arthritis Market is Forecast to Grow at a 4.6% CAGR from 2026 to 2036 As Biologics, JAK Inhibitors, and Emerging Targeted Therapies Reshape Pediatric Arthritis Treatment.
Real-world treatment patterns, healthcare resource utilization and economic burden in U.S. adults with schizophrenia with and without tardive dyskinesia
Single-cell transcriptome reveals keratinocyte subclusters contributing to altered differentiation and inflammatory responses in atopic dermatitis
Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight
Bristol Myers Wins FDA Review of Mezigdomide in Multiple Myeloma | Morningstar
Global consortium releases AI toolbox to unlock new Alzheimer's treatments
An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial
Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages
Kestra Advisory Services LLC Increases Holdings in Bristol Myers Squibb Company $BMY
Castleview Partners LLC Sells 11,554 Shares of Bristol Myers Squibb Company $BMY - Stock Observer
KLCM Advisors Inc. Sells 19,755 Shares of Bristol Myers Squibb Company $BMY
Candriam S.C.A. Cuts Stake in Bristol Myers Squibb Company $BMY
Bristol Myers Squibb Company $BMY Shares Sold by Conning Inc.
Did FTSE Russell's Reclassification and Dividend Streak Just Shift Bristol-Myers Squibb's (BMY) Investment Narrative?
Bristol Myers Squibb (NYSE:BMY) Price Target Cut to $66.00 by Analysts at Bank of America
Bank of America Issues Pessimistic Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price - Stock Observer
Summit Securities Group LLC Sells 82,290 Shares of Bristol Myers Squibb Company $BMY
U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals - NaturalNews.com
BristolMyers News
Alphabet (GOOGL) Stock Forecast 2026–2030: Where Could Google Stock Go as AI Spending Accelerates?
US Dollar Forecast 2026 (H2 Outlook): Will the USD Stay Strong Through Year-End?
Nvidia Stock Prediction 2030: Will It Hit a $10 Trillion Market Cap?
Latest news
Show more
Gold Price Today: Gold Rises Above $4,100 Ahead of Fed Meeting as Dollar Weakens
KOSPI Today: South Korean Stocks Rebound as Nvidia Investment Lifts Naver and AI Chipmakers
USD/JPY Drops Toward 163.50 as US Dollar Weakens on Easing Middle East Tensions
Bitcoin Price Today July 27: BTC Climbs Above $65,200 as Traders Await Fed Decision and Crypto Policy Developments
Stock Market News This Week: Fed, BoJ Lead a Packed Central Bank Week as Big Tech Earnings and Key US-China Data Take Center Stage
